Immunology Drugmaker Electra Seeks to Raise $347 Million in IPO
Electra Therapeutics Inc., a clinical-stage developer of immunology drugs, is seeking to raise as much as $347 million in a US initial public offering.
By Angel Adegbesan ยท Bloomberg
Electra Therapeutics Inc., a clinical-stage developer of immunology drugs, is seeking to raise as much as $347 million in a US initial public offering.